MBOT stock forecast
Our latest prediction for Microbot Medical, Inc.'s stock price was made on the Dec. 23, 2019 when the stock price was at 10.11$.
In the short term (2weeks), MBOT's stock price should underperform the market by -4.96%. During that period the price should oscillate between -13.21% and +22.64%.
In the medium term (3months), MBOT's stock price should underperform the market by -11.61%. During that period the price should oscillate between -46.12% and +39.57%.Get email alerts
About Microbot Medical, Inc.
Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.89$ per share.
The book value per share is 2.74$
Three months stock forecastDec. 23, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|